Sichuan Goldstone Asia Pharmaceutical Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 314.99 million compared to CNY 376.88 million a year ago. Revenue was CNY 314.99 million compared to CNY 376.88 million a year ago. Net income was CNY 66.58 million compared to CNY 78.9 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.17 compared to CNY 0.2 a year ago.